Genedrive: James Cheek, Gino Miele, David Budd
James Cheek has been appointed as CEO of UK-based molecular diagnostics firm Genedrive. He is succeeding David Budd, who stepped down as CEO. Cheek previously held positions at Cepheid, Beckman Coulter, and Roche Diagnostics.
In addition, CSO Gino Miele has been appointed as executive director of Genedrive. He was previously R&D director of Genedrive and the company's predecessor Epistem. Prior to that, he held associate director positions in personalized medicine at Wyeth and at Pfizer.